ストックスクリーナーアプリを入手
12.01
26.29%
2.50
アフターアワーズ：
11.95
-0.06
-0.50%
Elanco Animal Health Inc (ELAN) 最新ニュース
Health Care Stocks Climb As Companies Show Strong Gains - Finimize
Elanco (ELAN) Stock Target Raised by Analyst Amid Favorable Quarter | ELAN Stock News - GuruFocus
Elanco Animal Health (ELAN) Sees Strong Q1 Performance and Raises Outlook - GuruFocus
Elanco (ELAN) Stock Trades Up, Here Is Why - Yahoo Finance
Animal Health Elanco Chirps A Solid Quarter Tempered By Soft Q2 EPS Guide - Benzinga
Elanco Animal Health (ELAN) Raises Full-Year Revenue Outlook - GuruFocus
Transcript : Elanco Animal Health Incorporated, Q1 2025 Earnings Call, May 07, 2025 - marketscreener.com
Compared to Estimates, Elanco Animal Health (ELAN) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Elanco Animal Health Inc SEC 10-Q Report - TradingView
Elanco stock spikes after Q1 beat (ELAN:NYSE) - Seeking Alpha
Elanco Animal Health Beats Q1 Estimates, Faces Revenue Growth ChallengesNews and Statistics - IndexBox
Elanco (ELAN) Beats Earnings Estimates, Raises 2025 Revenue Guidance - GuruFocus
Elanco Animal Health Incorporated (ELAN) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance
Elanco Q1 2025 slides: Revenue guidance raised amid innovation-driven growth - Investing.com Canada
Elanco Animal Health beats Q1 estimates, shares rise over 3% By Investing.com - Investing.com South Africa
Elanco Animal Health beats Q1 estimates, shares rise over 3% - Investing.com Australia
Elanco (ELAN) Revises 2025 Revenue Forecast and Affirms Profit Projections | ELAN Stock News - GuruFocus
Elanco Animal Health Inc (ELAN) Q1 2025 Earnings: EPS of $0.13 Beats Estimate, Revenue at $1,193 Million Surpasses Expectations - GuruFocus
Elanco (NYSE:ELAN) Beats Q1 Sales Targets, Full-Year Outlook Slightly Exceeds Expectations - Yahoo Finance
Elanco (ELAN) Reports Strong Q1 Revenue with Raised 2025 Guidance | ELAN Stock News - GuruFocus
Elanco Animal Health Reports First Quarter 2025 Results | ELAN Stock News - GuruFocus
Elanco Animal Health Reports First Quarter 2025 Results - TradingView
Elanco Animal Health Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Elanco Animal Health Reports First Quarter 2025 Results – Company Announcement - Financial Times
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Acquired by First Trust Advisors LP - Defense World
US FDA approves Elanco's treatment for parasitic infections in dogs - AOL.com
Companion Animal Vaccine Market Is Booming So Rapidly 2025-2032 - openPR.com
Elanco (ELAN) Reports Q1: Everything You Need To Know Ahead Of Earnings - FinancialContent
Elanco Animal Health Sells Xdemvy Royalties To Blackstone in $295 Million Deal - Yahoo
Commit To Buy Elanco Animal Health At $8, Earn 13.1% Using Options - Nasdaq
Elanco Sells Xdemvy Royalty, Milestone Rights to Blackstone Affiliates for $295 Million - marketscreener.com
Elanco Sells Royalty and Milestone Rights for Lotilaner in Human - GuruFocus
Elanco Sells Royalty, Milestone Rights For Lotilaner In Human Health To Blackstone For $295 Mln Cash - Nasdaq
Elanco Sells Royalty And Milestone Rights For Lotilaner In Human Health To Blackstone Accelerates Debt Paydown - marketscreener.com
Elanco Cuts Debt With $295M Blackstone Deal: Key Details on Leverage Target and XDEMVY Royalty Sale - Stock Titan
Analyzing Ratios: Elanco Animal Health Inc (ELAN)’s Financial Story Unveiled - DWinneX
Renaissance Technologies LLC Has $760,000 Position in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Cyromazine Market Deep Research Report with Forecast by 2032 | - openPR.com
Elanco Animal Health Inc [ELAN] Shares Fall Approximately -28.51% Over the Year - knoxdaily.com
Earnings Preview: Elanco Animal Health Incorporated (ELAN) Q1 Earnings Expected to Decline - Yahoo Finance
Companion Animal Specialty Drugs Market Is Booming So Rapidly | Elanco, Dechra, Zomedica - openPR.com
Mariner LLC Buys 24,901 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
ELANCO ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Elanco Board Sued Over Safety, FDA Setbacks for Dog Itch Drug - Bloomberg Law News
Elanco Animal Health Inc (ELAN) Stock: A Comprehensive 52-Week Review - investchronicle.com
ELAN’s price-to-book ratio: An indicator of the company’s performance - uspostnews.com
A History of Outperforming Analyst Forecasts and Beating the Odds: Elanco Animal Health Inc (ELAN) - Sete News
Poultry Antibiotic Market Set to Witness Significant Growth - openPR.com
Press Release Distribution & PR Platform - ACCESS Newswire
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Purchased by Envestnet Asset Management Inc. - Defense World
Russell Investments Group Ltd. Decreases Stake in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Sold by Wells Fargo & Company MN - Defense World
Elanco Animal Health Inc [ELAN] Records 200-Day SMA of $12.48 - knoxdaily.com
COSM Stock Sees Surge of Approximately 15.01% in Last Five Days - knoxdaily.com
A company insider recently bought 125,000 shares of Opko Health Inc [OPK]. Should You Buy? - knoxdaily.com
A company insider recently bought 2,735 shares of Evolent Health Inc [EVH]. Should You Buy? - knoxdaily.com
Elanco or Zoetis? Sarat Sethi reveals his preferred stock - Invezz
Oscar Health Inc [OSCR] Records 50-Day SMA of $13.76 - knoxdaily.com
Elanco vs Zoetis stock: Sarat Sethi picks a side - TradingView
Animal Parasiticides Market Projected To Witness Substantial - openPR.com
Q1 EPS Estimate for Elanco Animal Health Reduced by Analyst - Defense World
Protect Your Dog from Deadly Parvo VirusElanco Animal Health - iHeart
Is Elanco Animal Health Inc. (NYSE:ELAN) the Best Cheap Stock to Buy Under $10? - Yahoo Finance
Are Elanco Animal Health Inc (ELAN) shares a good deal now? - uspostnews.com
Elanco Animal Health Inc Inc. (ELAN) Price Performance: The Role of Share Buybacks and Stock Splits - investchronicle.com
0.07%
23.23%
大文字化:
|
ボリューム (24 時間):